Increased Number of Shares and Votes in Hemfosa Fastigheter

STOCKHOLM--()--Regulatory News:

This constitutes information that Hemfosa Fastigheter AB (publ) (STO:HEMF) (STO:HEMFPREF) shall publish under the Securities Market Act and/or the Financial Instruments Trading Act. The information was issued for publication on 30 October 2015 at 8.00 am CET.

Hemfosa Fastigheter AB has, in accordance with information previously made public, conducted a new issue of 999,999 preference shares. The issue has resulted in an increased share capital and an increased number of shares and votes in Hemfosa.

On 30 October 2015, the total number of shares in Hemfosa Fastigheter amounts to 142,440,207, of which 131,440,208 are ordinary shares and 10,999,999 are preference shares. Each ordinary share entitles to one vote and each preference share entitles to one tenth of a vote. The total number of votes amounts to 132,540,208.9. Through the issue of preference shares Hemfosa's share capital has been increased by SEK 499,999.50 and amounts thereafter to SEK 71,220,103.50.

About Hemfosa Fastigheter

Hemfosa is a Swedish real estate company with a well-balanced and geographically diversified property portfolio focusing on community service properties with the State and municipalities as the largest tenants. This provides stable cash flows and a healthy yield. In order to create value, Hemfosa also aims to actively participate in the transaction market. As per 30 June 2015, Hemfosa owned commercial properties in Sweden with a total property value of approximately SEK 30 billion, including the company's share of the property value in joint ventures. The company's ordinary share has been listed since March 2014, and the preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.

This information was brought to you by Cision http://news.cision.com

Contacts

Hemfosa Fastigheter AB
Jens Engwall, CEO
mobile +46 70 690 65 50
office +46 8 448 04 80.
jens.engwall@hemfosa.se

Contacts

Hemfosa Fastigheter AB
Jens Engwall, CEO
mobile +46 70 690 65 50
office +46 8 448 04 80.
jens.engwall@hemfosa.se